These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

649 related items for PubMed ID: 16387393

  • 1. Physico-chemical characterization of disoxaril-dimethyl-beta-cyclodextrin inclusion complex and in vitro permeation studies.
    Ventura CA, Giannone I, Musumeci T, Pignatello R, Ragni L, Landolfi C, Milanese C, Paolino D, Puglisi G.
    Eur J Med Chem; 2006 Feb; 41(2):233-40. PubMed ID: 16387393
    [Abstract] [Full Text] [Related]

  • 2. Preparation of celecoxib-dimethyl-beta-cyclodextrin inclusion complex: characterization and in vitro permeation study.
    Ventura CA, Giannone I, Paolino D, Pistarà V, Corsaro A, Puglisi G.
    Eur J Med Chem; 2005 Jul; 40(7):624-31. PubMed ID: 15935897
    [Abstract] [Full Text] [Related]

  • 3. Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex.
    Jadhav GS, Vavia PR.
    Int J Pharm; 2008 Mar 20; 352(1-2):5-16. PubMed ID: 18023545
    [Abstract] [Full Text] [Related]

  • 4. Cyclodextrins as carriers for kavalactones in aqueous media: spectroscopic characterization of (S)-7,8-dihydrokavain and beta-cyclodextrin inclusion complex.
    Pescitelli G, Bilia AR, Bergonzi MC, Vincieri FF, Di Bari L.
    J Pharm Biomed Anal; 2010 Aug 01; 52(4):479-83. PubMed ID: 20185265
    [Abstract] [Full Text] [Related]

  • 5. Influence of modified cyclodextrins on solubility and percutaneous absorption of celecoxib through human skin.
    Ventura CA, Tommasini S, Falcone A, Giannone I, Paolino D, Sdrafkakis V, Mondello MR, Puglisi G.
    Int J Pharm; 2006 May 11; 314(1):37-45. PubMed ID: 16581211
    [Abstract] [Full Text] [Related]

  • 6. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM, Elkheshen SA, Ghorab MM.
    Eur J Pharm Biopharm; 2008 Nov 11; 70(3):819-27. PubMed ID: 18655829
    [Abstract] [Full Text] [Related]

  • 7. Novel inclusion complex of ibuprofen tromethamine with cyclodextrins: physico-chemical characterization.
    Al Omari MM, Daraghmeh NH, El-Barghouthi MI, Zughul MB, Chowdhry BZ, Leharne SA, Badwan AA.
    J Pharm Biomed Anal; 2009 Oct 15; 50(3):449-58. PubMed ID: 19545961
    [Abstract] [Full Text] [Related]

  • 8. Development of parenteral formulation for a novel angiogenesis inhibitor, CKD-732 through complexation with hydroxypropyl-beta-cyclodextrin.
    Kim JH, Lee SK, Ki MH, Choi WK, Ahn SK, Shin HJ, Hong CI.
    Int J Pharm; 2004 Mar 19; 272(1-2):79-89. PubMed ID: 15019071
    [Abstract] [Full Text] [Related]

  • 9. In vitro evaluation of natural and methylated cyclodextrins as buccal permeation enhancing system for omeprazole delivery.
    Figueiras A, Hombach J, Veiga F, Bernkop-Schnürch A.
    Eur J Pharm Biopharm; 2009 Feb 19; 71(2):339-45. PubMed ID: 18796330
    [Abstract] [Full Text] [Related]

  • 10. Formulation and biological evaluation of glimepiride-cyclodextrin-polymer systems.
    Ammar HO, Salama HA, Ghorab M, Mahmoud AA.
    Int J Pharm; 2006 Feb 17; 309(1-2):129-38. PubMed ID: 16377107
    [Abstract] [Full Text] [Related]

  • 11. Synthesis, characterization and in vitro evaluation of dimethyl-beta-cyclodextrin-4-biphenylylacetic acid conjugate.
    Ventura CA, Paolino D, Pedotti S, Pistarà V, Corsaro A, Puglisi G.
    J Drug Target; 2003 May 17; 11(4):233-40. PubMed ID: 14578110
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW, Kim MS, Kim JS, Park HJ, Lee S, Woo JS, Hwang SJ.
    Eur J Pharm Biopharm; 2007 Jun 17; 66(3):413-21. PubMed ID: 17240129
    [Abstract] [Full Text] [Related]

  • 14. Preformulation study of the inclusion complex warfarin-beta-cyclodextrin.
    Zingone G, Rubessa F.
    Int J Pharm; 2005 Mar 03; 291(1-2):3-10. PubMed ID: 15707726
    [Abstract] [Full Text] [Related]

  • 15. Sildenafil/cyclodextrin complexation: stability constants, thermodynamics, and guest-host interactions probed by 1H NMR and molecular modeling studies.
    Al Omari MM, Zughul MB, Davies JE, Badwan AA.
    J Pharm Biomed Anal; 2006 Jun 07; 41(3):857-65. PubMed ID: 16527440
    [Abstract] [Full Text] [Related]

  • 16. Preparation and characterisation of liposomes encapsulating ketoprofen-cyclodextrin complexes for transdermal drug delivery.
    Maestrelli F, González-Rodríguez ML, Rabasco AM, Mura P.
    Int J Pharm; 2005 Jul 14; 298(1):55-67. PubMed ID: 15941634
    [Abstract] [Full Text] [Related]

  • 17. In vitro and in vivo studies on the complexes of glipizide with water-soluble β-cyclodextrin-epichlorohydrin polymers.
    Nie S, Zhang S, Pan W, Liu Y.
    Drug Dev Ind Pharm; 2011 May 14; 37(5):606-12. PubMed ID: 21469949
    [Abstract] [Full Text] [Related]

  • 18. Physicochemical characteristics and bioavailability of a novel intestinal metabolite of ginseng saponin (IH901) complexed with beta-cyclodextrin.
    Lee PS, Han JY, Song TW, Sung JH, Kwon OS, Song S, Chung YB.
    Int J Pharm; 2006 Jun 19; 316(1-2):29-36. PubMed ID: 16574357
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Some pharmaceutical and inclusion properties of 2-hydroxybutyl-β-cyclodextrin derivative.
    Ishiguro T, Morishita E, Iohara D, Hirayama F, Wada K, Motoyama K, Arima H, Uekama K.
    Int J Pharm; 2011 Oct 31; 419(1-2):161-9. PubMed ID: 21839823
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.